LERA (TM) Cholesterol Reducing Formula
Natural health product licensed in Canada
- Other names
- Adaptogen Health Cholesterol Reducing Formula
- Licence holder
- Lerapharm Inc.
- NPN or DIN-HM
- 80058750
- Status
- Active licence
- Licence date
- 5 March 2015
- Revision date
- 9 October 2020
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Aralia elata Source : Racine Extract : Matériel brut sec Extraction ratio : 4.3:1 Dry plant equivalent : 42.57 mg | 9.9 mg | Not calculated |
| Crataegus laevigata Source : Crataegus laevigata - Fruit Extract : Matériel brut sec Extraction ratio : 4.3:1 Dry plant equivalent : 127.495 mg | 29.65 mg | Not calculated |
| Eleutherococcus senticosus Source : Eleutherococcus senticosus - racine Extract : Matériel brut sec Extraction ratio : 4.3:1 Dry plant equivalent : 170.02 mg | 39.54 mg | Not calculated |
| Glycyrrhiza uralensis Source : Glycyrrhiza uralensis, Root Extract : Matériel brut sec Extraction ratio : 4.3:1 Dry plant equivalent : 42.57 mg | 9.9 mg | Not calculated |
| Inonotus obliquus Source : Inonotus obliquus - En entier Extract : Matériel brut sec Extraction ratio : 4.3:1 Dry plant equivalent : 42.57 mg | 9.9 mg | Not calculated |
| Rhaponticum carthamoides Source : Racine Extract : Matériel brut sec Extraction ratio : 4.3:1 Dry plant equivalent : 85.14 mg | 19.8 mg | Not calculated |
| Rhodiola rosea Source : Rhodiola rosea - Racine Extract : Matériel brut sec Extraction ratio : 4.3:1 Dry plant equivalent : 42.57 mg | 9.9 mg | Not calculated |
| Schisandra chinensis Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 4.3:1 Dry plant equivalent : 42.57 mg | 9.9 mg | Not calculated |
| Sorbus aucuparia subsp. aucuparia Source : Sorbus aucuparia - fruit Extract : Matériel brut sec Extraction ratio : 4.3:1 Dry plant equivalent : 127.495 mg | 29.65 mg | Not calculated |
| Viburnum opulus Source : Fruit Extract : Matériel brut sec Extraction ratio : 4.3:1 Dry plant equivalent : 127.495 mg | 29.65 mg | Not calculated |
| bêta-glucane Source : Bêta-glucane | 3.5 g | Not calculated |
| 2-hydroxy-N,N,N-triméthyléthanaminium Source : Bitartrate de choline | 500 mg | Not calculated |
| Myo-Inositol Source : Inositol | 300 mg | Not calculated |
| L-Methionine Source : L-méthionine | 200 mg | Not calculated |
Non-medicinal ingredients
Maltodextrine, Dioxyde de silicium, Saveur de chocolat, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Mesures | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce (LDL) cholesterol which is one risk factor for the development of coronary heart disease. Provides support for healthy (postprandial) glucose metabolism. An adoptogenic formula to help in the normalization of body system functions altered by stress. A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80058750
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging